Zeria Pharmaceutical Co., Ltd.

4559 · TSE

Public Market Listing

4559TSE

TSE primary exchange listing

Live quotes, historical charts, and market capitalization for Zeria Pharmaceutical Co., Ltd. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Patiromer(Veltassa)
Phase 3
Gastrointestinal potassium binderSmall molecule
Chronic Kidney Disease

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2029 (1)
December 2029 (1)
Patiromer · VeltassaPhase 2Hyperkalemia
Est. primary completion 2029-12-01 · NCT05766839 · CT.gov ↗
What to watch

See the full readout calendar ↗

Financial reports

No financial reports recorded.